On this page you will find all of ACB’s publications. To the right are the search categories that will help you navigate around the ACB’s extensive work.
Despite the grave warnings of the COVID 19 pandemic and the increased need to de-colonise and de-corporatise our food systems and shift towards sovereignty, there continues to be an increase in the applications for genetically modified organisms (GMOs) of the 2,4-D variety, for introduction into the South African farming and food system.
The African Centre for Biodiversity (ACB) is extremely alarmed to learn that three genetically modified maize varieties developed by Corteva (new name of the Dow-DuPont merged entity) to withstand the application of the dangerous 2,4-D herbicide have been approved for general release by the Executiv
The Competition Tribunal announced the finalisation of the merger between Bayer and Monsanto in South Africa in May. Bayer had taken the original conditions imposed by the Competition Commission in 2017 to the Tribunal for reassessment. These included selling businesses to black economic empowerment (BEE) compliant companies.
ACB warns that the South African government has received an application for the commodity clearance (import for food, feed and processing) of ‘triple-stacked variety of genetically modified (GM) soya – MON 87708 X MON 89788 X A5547-127 by Monsanto South Africa (Pty) Ltd in October 2017.
ACB is objecting to the commodity clearance of the triple-stacked GM soybean event MON 87708 x MON 89788 x A5547-127, due to concerns surrounding the lack of safety assessment data for this crop and the known toxicity of the three pesticides it is designed to tolerate.
In 2015–2016 Dow AgroSciences Southern Africa (Pty) Ltd performed field trials on maize tolerant to 2,4-D (event DAS-87078-9) and stacked varieties carrying not only 2,4-D tolerance, but also glyphosate tolerance and/or Bt insectidal toxins.